In April 2025, Amgen announced a study is to evaluate the safety, tolerability, and to determine the maximum tolerated dose ...

Cervical cancer rates are on the rise among younger women, owing in part to a lack of screening and prevention.

Genmab has received approval from the Japan's Ministry of Health, Labour and Welfare for Tivdak (tisotumab vedotin) to treat ...

The Japanese Ministry of Health, Labour and Welfare on Thursday approved Genmab A/S’ (NASDAQ:GMAB) Tivdak (tisotumab vedotin) ...

Genmab has announced that the European Commission (EC) has approved Tivdak (tisotumab vedotin) to treat recurrent or ...

The company has also partnered with the Tata Institute for Genetics and Society (TIGS) to develop an Indigenous HPV PCR kit, ...

IN a powerful response to the World Health Organisation’s call for the global elimination of cervical cancer by 2030, ...

Certain strains of it can put you at higher risk of cervical cancer. HPV can also cause anal, throat, penile, vaginal, and vulvar cancers. Doctors advise everyone with a vagina to get tested for ...

Women in Papua New Guinea are being strongly encouraged to undergo early screening for cervical cancer to prevent the ...

The outcomes of this trial help confirm that cisplatin chemotherapy given adjuvantly with radiotherapy is not a superior alternative ,” said Sang Young Ryu, MD.

Poland’s cervical cancer prevention programme has been upgraded, offering improved early detection and education to reinforce ...

Japan approves Tivdak, the first ADC for cervical cancer ... TIVDAK compared to chemotherapy in patients with advanced or recurrent cervical cancer who were previously treated with chemotherapy.